Harvard Bioscience, Inc. Common Stock (NASDAQ: HBIO) last traded at $7.48, down 0.93% on the session. The quote above updates while this page is open; the figures below are drawn from Harvard Bioscience, Inc. Common Stock’s own filings and are restated only when a new one is published.
Harvard Bioscience, Inc. Common Stock trades on NASDAQ under the ticker HBIO. Its market capitalisation is $34.05 million.
Valuation measures for Harvard Bioscience, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $34.05M |
|---|---|
| Enterprise value | $96.42M |
| Price / sales | 0.39 |
| Price / book | 4.59 |
| Beta | 1.24 |
Trailing-twelve-month figures tagged in Harvard Bioscience, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $87.81M |
|---|---|
| Net income (TTM) | -$10.41M |
| Gross margin | 58.16% |
| Operating margin | -0.28% |
| Return on equity | -140.36% |
| Cash | $6.50M |
Range and volume for HBIO over the past 52 weeks.
| 52-week high | $9.40 |
|---|---|
| 52-week low | $3.80 |
| Volume | 10.2K |
| Average volume | 19.4K |
| Previous close | $7.55 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.